6 months ago
RYTM
AnalystsPhil NadeauPhil Nadeau's Stock Forecasts
AnalystsPhil Nadeau
Analyst Ranking
Top 14%
#653 out of 4875 analysts
Average Return
+26.12%
Win Rate
46%11 out of 24
Risk vs Reward
Poor
Good
Phil Nadeau's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | +740.17% | $5.85 | $49.15 | 2022-07-07 - 2023-07-06 | Buy |
Immunomedics IncIMMU | +195.08% | $7.72 | $22.78 | 2017-05-26 - 2018-05-25 | Buy |
Vertex Pharmaceuticals IncVRTX | +41.12% | $358.40 | $505.78 | 2023-08-02 - 2024-08-01 | Buy |
Vertex Pharmaceuticals IncVRTX | +38.80% | $245.39 | $340.60 | 2022-06-13 - 2023-06-12 | Buy |
Vertex Pharmaceuticals IncVRTX | +34.70% | $350.78 | $472.51 | 2023-06-28 - 2024-06-27 | Buy |
Phil Nadeau Analyst Color
Get additional color on Phil Nadeau's coverage of popular stocks
Phil Nadeau's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $65.00 | +13.28% | Maintains | 6 months ago |
Biogen IncBIIB | 5 | Strong Buy | $275.00 | +132.72% | Maintains | 6 months ago |
Biomarin Pharmaceutical IncBMRN | 1 | Strong Buy | $120.00 | +103.87% | Maintains | 9 months ago |
Vertex Pharmaceuticals IncVRTX | 7 | Strong Buy | $500.00 | +17.65% | Maintains | 10 months ago |
Phasebio Pharmaceuticals IncPHASQ | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Tricida IncTCDAQ | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Aura Biosciences IncAURA | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Icosavax IncICVX | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Lenz Therapeutics IncLENZ | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Ambrx Biopharma IncAMAM | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Annexon IncANNX | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Akouos IncAKUS | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Kezar Life Sciences IncKZR | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Q32 Bio IncQTTB | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Immunomedics IncIMMU | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.